These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15090273)
1. On the question of defining misadministration in brachytherapy: counterpoint. Amols HI; Zaider M Brachytherapy; 2002; 1(3):123-5. PubMed ID: 15090273 [No Abstract] [Full Text] [Related]
2. On the question of defining misadministration in brachytherapy: point. Williamson JF Brachytherapy; 2002; 1(3):121-3. PubMed ID: 15090272 [No Abstract] [Full Text] [Related]
3. In regard to Thomadsen et al.: Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques (Int J Radiat Oncol Biol Phys 2003;57:1492-1508). Patton GA Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):915; author reply 915-6. PubMed ID: 15183499 [No Abstract] [Full Text] [Related]
4. Point/Counterpoint. Miniature x-ray tubes will ultimately displace Ir-192 as the radiation sources of choice for high dose rate brachytherapy. Holt RW; Thomadsen BR; Orton CG Med Phys; 2008 Mar; 35(3):815-7. PubMed ID: 18404918 [No Abstract] [Full Text] [Related]
7. Counterpoint: Is there a need for supplemental XRT in intermediate-risk prostate cancer patients? Stone NN Brachytherapy; 2013; 12(5):393-7. PubMed ID: 23958340 [No Abstract] [Full Text] [Related]
8. Risk analysis using fuzzy set theory of the accidental exposure of medical staff during brachytherapy procedures. Castiglia F; Giardina M; Tomarchio E J Radiol Prot; 2010 Mar; 30(1):49-62. PubMed ID: 20220212 [TBL] [Abstract][Full Text] [Related]
9. Lessons learned from investigations of therapy misadministration events. Ostrom LT; Rathbun P; Cumberlin R; Horton J; Gastorf R; Leahy TJ Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):227-34. PubMed ID: 12118556 [TBL] [Abstract][Full Text] [Related]
11. The dosimetry of brachytherapy-induced erectile dysfunction. Merrick GS; Butler WM Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193 [TBL] [Abstract][Full Text] [Related]
12. [Remarks on the dosage problem in HDR brachytherapy]. Kneschaurek P Strahlenther Onkol; 1998 Sep; 174(9):468-72. PubMed ID: 9765688 [TBL] [Abstract][Full Text] [Related]
13. [A proposal for dosage and volume specification and documentation in HDR brachytherapy]. Krieger H; Baltas D; Kneschaurek P Strahlenther Onkol; 1996 Oct; 172(10):527-42. PubMed ID: 8966670 [TBL] [Abstract][Full Text] [Related]
14. Simulation study of high-dose-rate brachytherapy for early glottic cancer. Hoffman MR; McCulloch TM; Mohindra P; Das R; Geurts M; Harari PM Brachytherapy; 2016; 15(1):94-101. PubMed ID: 26614234 [TBL] [Abstract][Full Text] [Related]
15. Brachytherapy and breast cancer. White JR; Wilson JF Semin Surg Oncol; 1997; 13(3):190-5. PubMed ID: 9143057 [TBL] [Abstract][Full Text] [Related]